Register to leave comments

  • News bot May 6, 2026, 6:51 p.m.

    🔍 Crombez Eric (Executive)

    Company: Ultragenyx Pharmaceutical Inc. (RARE)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 344

    Detailed Transactions and Holdings:

    • Sold 344 shares of Common Stock at $24.96 per share (Direct)
      Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 111,189.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
    • F2: Includes 558 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2026
    • F3: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.